Basics Liquidia Technologies, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.32 | 3.38% Avg Daily Range (30 D): $0.94 | 3.39% Avg Daily Range (90 D): $0.74 | 2.91% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): 2.04M Avg Daily Volume (90 D): 2.31M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 900 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $2.7M Avg Inst. Trade (90 D): $3.03M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.37M Avg Closing Trade (30 D): $4.87M Avg Closing Trade (90 D): $5.3M Avg Closing Volume: 165.06K     News Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.47 $-.04 $-.49 Diluted EPS $-1.47 $-.04 $-.49 Revenue $ 69.22M $ 54.34M $ 8.84M Gross Profit $ $ $ Net Income / Loss $ -124.09M $ -3.53M $ -41.58M Operating Income / Loss $ -107.27M $ 1.77M $ -37.51M Cost of Revenue $ $ $ Net Cash Flow $ -43.37M $ -15.93M $ 7.17M PE Ratio